Hillhouse Capital Advisors Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Hillhouse Capital Advisors Ltd
CIK #0001762304
Sector Form 13F Holdings Value ($B)
Pinduoduo Inc 0.4
Alibaba Group Holding Ltd 0.3
BeiGene Ltd 0.3
FUTU Holdings Ltd 0.2
Legend Biotech Corp 0.1
Arrivent Biopharma Inc 0.1
KE Holdings Inc 0.1
Cytek Biosciences Inc 0.0
Marvell Technology Inc 0.0
I-Mab 0.0
View All
Holdings by Sector ($B)
151296302011201620212027
EDGAR Form CIK 2011 - 2026
13F-HR [0001762304]
3 [0001762304]
4 [0001762304]
SC 13D [0001762304]
SC 13G [0001762304]
Form 13D/13G Filer Form 13D/13G Subject Filed
HHLR Advisors Ltd Arrivent Biopharma Inc [2024-11-14]
HHLR Advisors Ltd Agora Inc [2022-02-14]
HHLR Advisors Ltd Cytek Biosciences Inc [2022-02-14]
HHLR Advisors Ltd on Holding AG [2022-02-14]
HHLR Advisors Ltd Smart Share Global Ltd [2021-09-27]
Hillhouse Capital Advisors Ltd Aligos Therapeutics Inc [2021-02-16]
Hillhouse Capital Advisors Ltd Leap Therapeutics Inc [2021-02-16]
Hillhouse Capital Advisors Ltd Miniso Group Holding Ltd [2021-02-16]
Hillhouse Capital Advisors Ltd Root Inc [2021-02-16]
Hillhouse Capital Advisors Ltd Beam Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
ArriVent BioPharma Inc
HHLR Advisors Ltd
Hillhouse Investment Management Ltd
BeOne Medicines Ltd
EastBridge Investment Group Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
ArriVent BioPharma Inc AVBP
Common Stock
2025-12-10 Sell 555,555 $23.37 12,983,320
BeOne Medicines Ltd BGNE
Ordinary Shares
2024-12-02 Sell 17,842,500 $200.00 3,568,500,000
ArriVent BioPharma Inc AVBP
Series A Preferred Stock · derivative
2024-01-30 Conversion 55,000,000 $0.00
ArriVent BioPharma Inc AVBP
Common Stock
2024-01-30 Conversion 3,616,041
ArriVent BioPharma Inc AVBP
Common Stock
2024-01-30 Buy 555,555 $18.00 9,999,990
ArriVent BioPharma Inc AVBP
Series B Preferred Stock · derivative
2024-01-30 Conversion 4,761,903 $0.00
ArriVent BioPharma Inc AVBP
Common Stock
2024-01-30 Conversion 313,076
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-14 Sell 273,728 $207.72 56,858,780
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-13 Sell 611,000 $211.45 129,195,950
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-13 Sell 313,400 $128.43 40,249,962
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-12 Sell 968,812 $213.91 207,238,575
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-12 Sell 281,400 $130.83 36,815,562
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-09 Sell 328,952 $217.02 71,389,163
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-09 Sell 213,700 $130.35 27,855,795
BeOne Medicines Ltd BGNE
Ordinary Shares
2023-06-08 Sell 1,163,825 $218.14 253,876,785
BeOne Medicines Ltd BGNE
Ordinary Shares
2022-08-22 Other 7,800 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com